Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Alpelisib × Clear all

Phase

Phase 1 26 Phase 2 22 Phase 1/2 8 Phase 3 7 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Exercise 363 Blood Specimen Collection 291 Standard of Care 271 Magnetic Resonance Spectroscopy 234 Radiotherapy 224 Surveys and Questionnaires 208 Radiosurgery 208 Educational Status 200 Methods 197 Early Intervention, Educational 181 Practice Guidelines as Topic 128 Biopsy 123 Interviews as Topic 122 Drug Therapy 118 Control Groups 116 Surgical Procedures, Operative 114 Acupuncture Therapy 112 Cyclophosphamide 91 Therapeutics 90 Palliative Care 90 Counseling 86 Magnetic Resonance Imaging 78 Resistance Training 76 Cisplatin 75 Saline Solution 73 Radiofrequency Ablation 73 Radiotherapy, Intensity-Modulated 71 Specimen Handling 68 Colonoscopy 68 Cognitive Behavioral Therapy 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801966 2023-05-10

TAILOR

Peter MacCallum Cancer Centre, Australia

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡